ENTX vs PFE · $58.2M cap vs P/E 20, rev $15.03B
Entera Bio Ltd (ENTX) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Entera Bio Ltd (ENTX) is a biotechnology company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported ENTX revenue for 2026-06-30 was $0. Net income was -$10.8M. ENTX currently screens at market cap $58.2M.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
ENTX currently screens at market cap $58.2M. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the ENTX and PFE stock pages for the full models.
Not investment advice.